Purdue Pharma owners agree to pay £6bn in new settlement over OxyContin toll

Purdue Pharma owners agree to pay £6bn in new settlement over OxyContin toll
Members of the family who own OxyContin maker Purdue Pharma have agreed to pay up to 7.4 billion dollars in a new settlement (Alamy/PA)

Members of the family who own OxyContin maker Purdue Pharma have agreed to pay up to 7.4 billion dollars (£6 billion) in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York Attorney General Letitia James said.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, represents an increase of more than a billion dollars over a previous settlement deal that was rejected last year by the US Supreme Court.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited